- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.3450
4.4900
52 wk Range
3.6450
21.4004
Neuphoria Therapeutics (NEUP) Technical Analysis
Assess Neuphoria Therapeutics (NEUP) technical analysis based on moving-average signals and common indicators such as RSI, MACD and CCI, ranging from strong buy to strong sell. Review the NEUP signals across a customisable timeframe to decide whether the stock is a buy or sell for your personal share portfolio.
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Summary:Strong Sell
| Moving Averages: | Strong Sell | Buy: (1) | Sell: (11) |
| Technical Indicators: | Strong Sell | Buy: (1) | Sell: (7) |
Technical Indicators
Summary: Strong SellBuy: 1Neutral: 2Sell: 7
Jun 26, 2026 07:11 GMT
Name | Value | Action | ||
|---|---|---|---|---|
| RSI(14) | 47.579 | Neutral | ||
| STOCH(9,6) | 48.882 | Neutral | ||
| STOCHRSI(14) | 20.398 | Oversold | ||
| MACD(12,26) | 0.018 | Buy | ||
| ADX(14) | 27.594 | Sell | ||
| Williams %R | -68.182 | Sell | ||
| CCI(14) | -67.8773 | Sell | ||
| ATR(14) | 0.069 | Less Volatility | ||
| Highs/Lows(14) | -0.0121 | Sell | ||
| Ultimate Oscillator | 45.171 | Sell | ||
| ROC | -1.361 | Sell | ||
| Bull/Bear Power(13) | -0.048 | Sell | ||
Moving Averages
Summary: Strong SellBuy: 1Sell: 11
Jun 26, 2026 07:11 GMT
Name | Simple | Exponential | |||
|---|---|---|---|---|---|
| MA5 | 4.4140 Sell | | 4.3974 Sell | | |
| MA10 | 4.3970 Sell | | 4.3992 Sell | | |
| MA20 | 4.3990 Sell | | 4.3840 Sell | | |
| MA50 | 4.3473 Buy | | 4.3904 Sell | | |
| MA100 | 4.4465 Sell | | 4.4931 Sell | | |
| MA200 | 4.7642 Sell | | 4.6388 Sell | | |
Pivot Points
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 4.3366 | 4.3633 | 4.3766 | 4.4033 | 4.4166 | 4.4433 | 4.4566 |
| Fibonacci | 4.3633 | 4.3786 | 4.388 | 4.4033 | 4.4186 | 4.428 | 4.4433 |
| Camarilla | 4.379 | 4.3827 | 4.3863 | 4.4033 | 4.3937 | 4.3973 | 4.401 |
| Woodie's | 4.33 | 4.36 | 4.37 | 4.4 | 4.41 | 4.44 | 4.45 |
| DeMark's | - | - | 4.37 | 4.4 | 4.41 | - | - |
FAQ
Is Neuphoria Therapeutics (NEUP) a Buy or Sell, from a Technical Analysis Perspective?
Based on moving averages and other technical indicators, today's Neuphoria Therapeutics buy/sell signal is Strong Sell.
What Do The Current Moving Averages for Neuphoria Therapeutics (NEUP) Show?
The moving averages for Neuphoria Therapeutics show a Strong Sell outlook, considering moving averages ranging from MA5 to MA200, with 0 Buy signals and 12 Sell signals.
What Do Today's Technical Indicators for Neuphoria Therapeutics Show?
The technical indicators for Neuphoria Therapeutics are in a Strong Sell position based on daily analysis, with 2 signals on buy indicators and 6 sell signals.
What Is Neuphoria Therapeutics (NEUP)'s 14-Day RSI?
The current Relative Strength Index (RSI) of NEUP over the 14-day period is 47.579, which suggests that the stock is a Neutral.
What Is Neuphoria Therapeutics (NEUP)'s MACD?
NEUP's MACD (Moving Average Convergence/Divergence) is 0.018, which suggests that the stock is a Buy.
What Is Neuphoria Therapeutics (NEUP)'s 5-Day Moving Average?
NEUP's 5-day moving average is 4.4140, suggesting that the stock is a Sell.
What Is Neuphoria Therapeutics (NEUP)'s 50-Day Moving Average?
NEUP's 50-day moving average is 4.3473, suggesting that the stock is a Buy.
What Is Neuphoria Therapeutics (NEUP)'s 200-Day Moving Average?
NEUP's 200-day moving average is 4.7642, suggesting that the stock is a Sell.
What Is the Fibonacci Pivot Point Performance Value for Neuphoria Therapeutics (NEUP)?
The Fibonacci pivot point performance value for NEUP is 4.4033.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.